RegeneRx Biopharmaceuticals, Inc.

The current price of RGRX is 0.0014 USD — it has decreased by 97.32% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange RegeneRx Biopharmaceuticals, Inc. stocks are traded under the ticker RGRX.

RegeneRx Biopharmaceuticals, Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.

RGRX stock is ‪3.63 K‬% volatile and has beta coefficient of −42.08. Check out the list of the most volatile stocks — is RegeneRx Biopharmaceuticals, Inc. there?

Yes, you can track RegeneRx Biopharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.

Today RegeneRx Biopharmaceuticals, Inc. has the market capitalization of ‪2.10 K‬, it has increased by ‪3.63 K‬% over the last week.

No, RGRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, RGRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RegeneRx Biopharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.

RGRX reached its all-time high on Mar 23, 1987 with the price of 2650.0000 USD, and its all-time low was 0.0002 USD and was reached on Oct 18, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 23, 2024, the company has 2.00 employees. See our rating of the largest employees — is RegeneRx Biopharmaceuticals, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RegeneRx Biopharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RegeneRx Biopharmaceuticals, Inc. stock shows the sell signal. See more of RegeneRx Biopharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.